Abstract
Background: Anti-tuberculosis drug resistant is a major public health problem worldwide. It arises due
to improper use of anti-tuberculous drugs in susceptible TB patients. The objectives of this study were
to evaluate treatment outcomes and adverse effects of drug resistant tuberculosis patients. Methods: A
descriptive cross-sectional study was conducted in two Programmatic Management of Drug Resistant
Tuberculosis (PMDT) sites of Sukkur and Larkana. The sociodemographic data was obtained by a set
of questionnaire following WHO guidelines. Adverse drug effects and treatment outcome data was
gathered from their medical files. Results: Of a total 938 patients, 535 (57.1%) were male and 403
(42.9%) were female. Their mean age was 35.95±14.4 years in Sukkur and 35.46±11 years in Larkana.
Married patients were 69%, illiterate were 46.3%, farmers 36.8%, lower class 60.4%, and rural were
68.8% patients. Previously treated cases were 83%. The MDR-TB cases were 82.8%. Diabetes mellitus
as co-morbidity was 11.2%, and 41.3% were smokers. The adverse effects developed in 68.4%
patients. Overall successful treatment outcome rate was 53.9%. Conclusion: Treatment outcome of
drug resistant TB patients was quite low, and 68.4% patients developed adverse effects. Artharlgia was
the most common adverse effect.
